# Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis

Page: https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis
Text version: https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis.md
Podcast: [The IMID Forum](https://stenobird.com/podcast/the-imid-forum-981476)
Published: 2026-05-15T10:59:08+00:00
Episode link: https://soundcloud.com/imidforum/discussing-axspa-biologic
Audio file: https://feeds.soundcloud.com/stream/2320500257-imidforum-discussing-axspa-biologic.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis
Duration seconds: 1315

## Resource

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares in high-risk axSpA and the effect of secukinumab dose escalation on MRI inflammation and damage in axSpA.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-biologic-therapy-outcomes-in-axial-spondyloarthritis.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.